PO12 | Characterisation and real word clinical data of HEM006, a newly formulated intranasal spray desmopressin (DDAVP) to address a global treatment gap: G. De Giorgi1, A. Gringeri2, R. Franceschini1, A. Koganti3 | 1Hemorare Srl, Italy; 2Fondazione Charta, Milan, Italy; 3Quenya LLC, USA. Bleeding Thromb Vasc Biol [Internet]. 2025 Oct. 22 [cited 2026 Apr. 25];4(s1). Available from: https://www.btvb.org/btvb/article/view/274